Medivo Partners with American Association of Clinical Endocrinologists


Medivo Partners with American Association of Clinical Endocrinologists

Leading Endocrinology Group Selects Medivo to Deliver Health Analytics and 'Big Data' Services to Its Membership

NEW YORK--(BUSINESS WIRE)-- Medivo Inc., a health monitoring company for physicians and their patients, announced today that it has partnered with the American Association of Clinical Endocrinologists (AACE) to deliver high-value registry and quality-improvement services to AACE members and their patients with endocrinology-related conditions, including diabetes, thyroid diseases, osteoporosis and metabolism disorders, among others. Medivo services will be offered with AACE oversight to clinicians treating patients with these conditions.

Medivo currently provides health monitoring and care management services to tens of thousands of physicians and over 1 million patients. With the new partnership and Medivo's data analytics services, AACE will be well-positioned to conduct registry research, publish results that highlight ongoing improvements in endocrinology and identify gaps in care that need to be addressed.

"AACE is pleased to partner with Medivo in order to offer robust new benefits to AACE members and their patients," said AACE president Alan J. Garber, MD, Ph.D., FACE. "Providing Medivo's services free of charge to our members will provide opportunities for immediate and measurable improvements in care, as well as new research to guide best practices using aggregate data from leading endocrinology practices across the United States."

In addition, AACE will assist in enhancing Medivo's existing endocrinology platform and the research tools already developed by Medivo to help save and improve lives through faster access to quality health care. The collaborative effort also benefits patients, their families, and caregivers, by making it easier to access resources that provide condition updates and tools designed to help improve their health and quality of life.

"We at Medivo are excited by this opportunity to collaborate with AACE to build a foundation for helping all physicians who treat endocrinology disorders to provide higher quality care with clearer views on their patients' clinical datasets," said Medivo EVP and co-founder Destry Sulkes, MD, MBA. "The collaboration aligns with the goals of the Affordable Care Act and will help practices in their efforts to focus on preventive care."

About Medivo

Headquartered in New York City, Medivo is a health monitoring company dedicated to helping save and improve lives through faster and easier access to quality healthcare. The Medivo platform collects clinical data from labs and symptom data from apps and devices to help physicians provide better care and help their patients more effectively monitor their health. Medivo enables patients to better manage their health and have more meaningful interactions with their doctors through access to testing and mobile symptom monitoring tools, easy-to-understand explanations of lab results, and relevant education information. For more information, visit our website at, follow us on Twitter @gomedivo or Like Us on Facebook.

About AACE

The American Association of Clinical Endocrinologists (AACE) represents more than 6,500 endocrinologists in the United States and abroad. AACE is the largest association of clinical endocrinologists in the world. The majority of AACE members are certified in Endocrinology and Metabolism and concentrate on the treatment of patients with endocrine and metabolic disorders including diabetes, thyroid disorders, osteoporosis, growth hormone deficiency, cholesterol disorders, hypertension and obesity. For more information, visit the AACE website at, become a fan on Facebook at or follow AACE on Twitter at

Medivo Inc.
Mark Tosh
Director of Corporate Communications

KEYWORDS: United States North America New York


The article Medivo Partners with American Association of Clinical Endocrinologists originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.